Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls

摘要

Genetic testing has been conducted in patients with prostate cancer (PCa) using multigene panels, but no centralized guidelines for genetic testing exist. To overcome this limitation, we investigated the demographic and clinical characteristics of patients with pathogenic variants.